Evidence map›Paper›PMID 33048870›Full record

ArticleAIDS (London, England)2020

Hazardous alcohol use, antiretroviral therapy receipt, and viral suppression in people living with HIV who inject drugs in the United States, India, Russia, and Vietnam.

Jennifer A Wagman, Adriane Wynn, Mika Matsuzaki, Natalia Gnatienko, Lisa R Metsch, Carlos Del Rio, Daniel J Feaster, Robin M Nance, Bridget M Whitney, Joseph A C Delaney and 14 more

Open access · greenAbstract read
In one paragraph

Article in AIDS (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 1 institution in 1 country.

Jennifer A WagmanDepartment of Community Health Sciences, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California, USA.
Adriane Wynn
Mika Matsuzaki
Natalia Gnatienko
Lisa R Metsch
Carlos Del Rio
Daniel J Feaster
Robin M Nance
Bridget M Whitney
Joseph A C Delaney
Shoshana Y Kahana
Heidi M Crane
Redonna K Chandler
Jennifer C Elliott
Frederick Altice
Gregory M Lucas
Shruti H Mehta
Yael Hirsch-Moverman
Wafaa M El-Sadr
Quan Vu
Binh Nguyen Thanh
Sandra A Springer
Judith I Tsui
Jeffrey H Samet
University of California, Los Angeles · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI CURT G BECKWITH, DEBBIE M. CHENG · 1998 to 2026
$51.7M
Enhanced Access to HIV Care for Drug Users in San Juan, Puerto RicoR01DA035280 · NIDA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI METSCH, LISA R, SANTANA-BAGUR, JORGE L. · 2013 to 2017
$9.5M
Training Program in Substance Use, HIV and Related InfectionsT32DA023356 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Natasha Martin, Steffanie A Strathdee · 2007 to 2026
$7.8M
Strategies to improve the HIV care continuum among key populations in IndiaR01DA041034 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M, MEHTA, SHRUTI H · 2015 to 2021
$6.7M
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSMR01DA032106 · NIDA · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DUERR, ANN C · 2011 to 2015
$6.6M
Integrated Care Clinics for IDUs in India: a cluster randomized trialR01DA032059 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LUCAS, GREGORY M, MEHTA, SHRUTI H · 2011 to 2015
$6.3M
Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine UsersR01DA032098 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DEL RIO, CARLOS, METSCH, LISA R · 2011 to 2015
$6.2M
Naltrexone for Opioid Dependent Released HIV+ Criminal Justice PopulationsR01DA030762 · NIDA · YALE UNIVERSITY · PI SPRINGER, SANDRA ANN · 2010 to 2015
$4.1M
HIV, Buprenorphine, and the Criminal Justice SystemR01DA030768 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2010 to 2015
$4.0M
Seek, Test, Treat, and Retain Data Harmonization Coordinating CenterU01DA037702 · NIDA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., DELANEY, JOSEPH AUSTIN · 2014 to 2019
$3.8M
NCATS NIH HHS UL1 TR001863NIAAA NIH HHS K01 AA024068NIAAA NIH HHS K01 AA027733NIAAA NIH HHS K23 AA023753NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI042853NIDA NIH HHS K02 DA032322NIDA NIH HHS K24 DA017072NIDA NIH HHS K24 DA035684NIDA NIH HHS R01 DA030762NIDA NIH HHS R01 DA030768NIDA NIH HHS R01 DA030776NIDA NIH HHS R01 DA032057NIDA NIH HHS R01 DA032059NIDA NIH HHS R01 DA032082NIDA NIH HHS R01 DA032098NIDA NIH HHS R01 DA032100NIDA NIH HHS R01 DA032106NIDA NIH HHS R01 DA032110NIDA NIH HHS R01 DA035280NIDA NIH HHS R01 DA041034NIDA NIH HHS T32 DA023356NIDA NIH HHS U01 DA037702
6 · The paper itself

Abstract

objectivesIn high-income countries, hazardous alcohol use is associated with reduced receipt of antiretroviral therapy (ART) and viral suppression among people living with HIV (PLHIV) who inject drugs. These associations are less understood in lower middle-income countries (LMIC) and upper middle-income countries.

designWe examined associations between hazardous alcohol use, ART receipt, and viral suppression among PLHIV who reported current or former injection drug use. Participants were from nine studies in the United States (high-income country), India (LMIC), Russia (upper middle-income country), and Vietnam (LMIC).

methodsHazardous alcohol use was measured via Alcohol Use Disorders Identification Test. Outcomes were HIV viral suppression (viral load of <1000 RNA copies/ml) and self-reported ART receipt. Logistic regression assessed associations between hazardous alcohol use and both outcome variables, controlling for age and sex, among participants with current and former injection drug use.

resultsAmong 2790 participants, 16% were women, mean age was 37.1 ± 9.5 years. Mean Alcohol Use Disorders Identification Test scores were 4.6 ± 8.1 (women) and 6.2 ± 8.3 (men); 42% reported ART receipt; 40% had viral suppression. Hazardous alcohol use was significantly associated with reduced ART receipt in India (adjusted odds ratio = 0.59, 95% confidence interval: 0.45-0.77, P < 0.001); and lower rates of viral suppression in Vietnam (adjusted odds ratio = 0.51, 95% confidence interval: 0.31-0.82, P = 0.006).

conclusionAssociations between hazardous alcohol use, ART receipt, and viral suppression varied across settings and were strongest in LMICs. Addressing hazardous alcohol use holds promise for improving HIV continuum of care outcomes among PLHIV who inject drugs. Specific impact and intervention needs may differ by setting.

Indexed as

Alcohol-Related DisordersAnti-Retroviral AgentsHIV InfectionsSubstance Abuse, IntravenousAdultCross-Sectional StudiesFemaleHumansIndiaMaleMiddle AgedRussiaUnited StatesVietnamViral LoadAnti-Retroviral Agents

Identifiers

PMID33048870
PMCPMC7951611
OpenAlexW3092240045

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.